Novel HGPRT 293 A>G point mutation presenting as neonatal acute renal failure

Pediatr Nephrol. 2008 Feb;23(2):317-21. doi: 10.1007/s00467-007-0612-1. Epub 2007 Oct 13.

Abstract

We report on a rare case of hypoxanthine guanine phosphoribosyl transferase (HGPRT) deficiency that presented in the newborn period with acute renal failure (ARF). The clinical diagnosis was made on the basis of non-oliguric ARF and evidence of crystal nephropathy on renal biopsy. HGPRT deficiency was eventually confirmed by enzymatic and genetic testing, showing a novel point mutation, 293 A>G. Immediate treatment consisted of peritoneal dialysis with, initially, lactate- then bicarbonate-buffered 1.36% glucose solution together with oral administration of allopurinol. Follow-up after more than 4 years continued to show hyper-echogenic kidneys with almost normal renal glomerular function. There continues to be no neurobehavioural abnormalities.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / diagnosis
  • Acute Kidney Injury / etiology
  • Acute Kidney Injury / genetics*
  • Acute Kidney Injury / therapy
  • Allopurinol / therapeutic use
  • Combined Modality Therapy
  • Follow-Up Studies
  • Gout Suppressants / therapeutic use
  • Hemodialysis Solutions
  • Humans
  • Hypoxanthine Phosphoribosyltransferase / deficiency
  • Hypoxanthine Phosphoribosyltransferase / genetics*
  • Hypoxanthine Phosphoribosyltransferase / metabolism
  • Infant, Newborn
  • Kidney / diagnostic imaging
  • Lesch-Nyhan Syndrome / complications
  • Lesch-Nyhan Syndrome / diagnosis
  • Lesch-Nyhan Syndrome / genetics*
  • Lesch-Nyhan Syndrome / therapy
  • Male
  • Peritoneal Dialysis
  • Point Mutation*
  • Treatment Outcome
  • Ultrasonography

Substances

  • Gout Suppressants
  • Hemodialysis Solutions
  • Allopurinol
  • Hypoxanthine Phosphoribosyltransferase